Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Joubert

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Australian Family Physician|August 23, 2005
Migraine--diagnosis and treatmentJacques Joubert
Expert Opinion on Therapeutic Patents|October 26, 2018
Bicyclic bis-heteroaryl derivatives as inhibitors of the α-synuclein protein: a patent evaluation of WO2018138088A1Jacques Joubert
Australian Family Physician|August 23, 2005
Diagnosing headacheJacques Joubert
Bioorganic & Medicinal Chemistry Letters|March 14, 2020
Discovery of 9-phenylacridinediones as highly selective butyrylcholinesterase inhibitors through structure-based virtual screeningJacques Joubert, Erika Kapp
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological DisordersAyodeji Olatunde Egunlusi, Jacques Joubert
Expert Opinion on Therapeutic Patents|February 23, 2011
Novel nitric oxide synthase inhibitors: a patent reviewJacques Joubert, Sarel F Malan
Journal of Pharmaceutical Policy and Practice|March 2, 2023
Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022Lerato Moeti, Madira Litedu, Jacques Joubert
Therapeutic Innovation & Regulatory Science|December 3, 2021
Common Deficiencies Found in the Active Pharmaceutical Ingredient (API) Section of Non-sterile Generic Products Submitted for Registration by SAHPRALerato Moeti, Madira Litedu, Jacques Joubert
Pharmaceutical Medicine|January 4, 2023
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA)Lerato Moeti, Madira Litedu, Jacques Joubert
Therapeutic Innovation & Regulatory Science|July 27, 2022
Bioequivalence Common Deficiencies in Generic Products Submitted for Registration to the South African Health Products Regulatory Authority (SAHPRA)Lerato Moeti, Madira Litedu, Jacques Joubert
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Australian Family Physician|August 23, 2005
Migraine--diagnosis and treatmentJacques Joubert
Expert Opinion on Therapeutic Patents|October 26, 2018
Bicyclic bis-heteroaryl derivatives as inhibitors of the α-synuclein protein: a patent evaluation of WO2018138088A1Jacques Joubert
Australian Family Physician|August 23, 2005
Diagnosing headacheJacques Joubert
Bioorganic & Medicinal Chemistry Letters|March 14, 2020
Discovery of 9-phenylacridinediones as highly selective butyrylcholinesterase inhibitors through structure-based virtual screeningJacques Joubert, Erika Kapp
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological DisordersAyodeji Olatunde Egunlusi, Jacques Joubert
Expert Opinion on Therapeutic Patents|February 23, 2011
Novel nitric oxide synthase inhibitors: a patent reviewJacques Joubert, Sarel F Malan
Journal of Pharmaceutical Policy and Practice|March 2, 2023
Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022Lerato Moeti, Madira Litedu, Jacques Joubert
Therapeutic Innovation & Regulatory Science|December 3, 2021
Common Deficiencies Found in the Active Pharmaceutical Ingredient (API) Section of Non-sterile Generic Products Submitted for Registration by SAHPRALerato Moeti, Madira Litedu, Jacques Joubert
Pharmaceutical Medicine|January 4, 2023
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA)Lerato Moeti, Madira Litedu, Jacques Joubert
Therapeutic Innovation & Regulatory Science|July 27, 2022
Bioequivalence Common Deficiencies in Generic Products Submitted for Registration to the South African Health Products Regulatory Authority (SAHPRA)Lerato Moeti, Madira Litedu, Jacques Joubert
Pageof 7